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Abstract. Insulin stimulates glucose transport in
adipocytes via the rapid redistribution of the GLUT!
and GLUT4 glucose transporters from intracellular
membrane compartments to the cell surface. Insulin
sensitivity is dependent on the proper intracellular
trafficking of the glucose transporters in the basal
state. The bulk of insulin-sensitive transport in adipo-
cytes appears to be due to the translocation of
GLUT4, which is more efficiently sequestered inside
the cell and is present in much greater abundance than
GLUTI.
The cell type and isoform specificity of GLUT4 in-
tracellular targeting were investigated by examining the
subcellular distribution of GLUTI and GLUT4 in cell
types that are refractory to the effect of insulin on glu-
cose transport. Rat GLUT4 was expressed in 3T3-LI
fibroblasts and HepG2 hepatoma cells by DNA-
mediated transfection. Transfected 3T3-Ll fibroblasts
over-expressing human GLUTI exhibited increased
glucose transport, and laser confocal immunofluores-
cent imaging of GLUTI in these cells indicated that
the protein was concentrated in the plasma membrane.
In contrast, 3T3-Ll fibroblasts expressing GLUT4 ex-
hibited no increase in transport activity, and confocal
imaging demonstrated that this protein was targeted al-
most exclusively to cytoplasmic compartments. 3T3-Ll
fibroblasts expressing GLUT4 were unresponsive to
r.UCOSE, an essential nutrient for many mammalian
cells, istransportedacross theplasma membrane via
facilitative carrierproteins. Fiveglucosetransporter
isoforms have been described thus far (for reviews, see
Gould and Bell, 1990; Mueckler, 1990). These are named
GLUTI through GLUT5 in order oftheir identification by
means of cDNA cloning. The five transporter isoforms are
distinguished by their discrete tissue distributions, kinetic
properties, and regulation. In most cell types, such as en-
dothelial cells, hepatocytes, and parenchymal cells of the
brain, glucose transportisprobably notratelimiting forglu-
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insulin with respect to transport activity, and no
change was observed in the subcellular distribution of
the protein after insulin administration . Immunogold
labeling of frozen ultrathin sections revealed that
GLUT4 was concentrated in tubulo-vesicular elements
of the trans-Golgi reticulum in these cells. Sucrose
density gradient analysis of 3T3-Ll homogenates was
consistent with the presence of GLUT! and GLUT4 in
discrete cytoplasmic compartments. Immunogold label-
ing of frozen thin sections of HepG2 cells indicated
that endogenous GLUT! was heavily concentrated in
the plasma membrane. Sucrose density gradient analy-
sis ofhomogenates of HepG2 cells expressing rat
GLUT4 suggested that GLUT4 is targeted to an intra-
cellular location in these cells. The density of the
putative GLUT4-containing cytoplasmic membrane
vesicles was very similar in HepG2 cells, 3T3-Ll
fibroblasts, 3T3-LI adipocytes, and rat adipocytes.
These data indicate that the intracellular trafficking of
GLUT4 is isoform specific. Additionally, these obser-
vations support the notion that GLUT4 is targeted to
its proper intracellular locale even in cell types that do
not exhibit insulin-responsive glucose transport, and
suggest that the machinery that regulates the intracel-
lular targeting of GLUT4 is distinct from the factors
that regulate insulin-dependent recruitment to the cell
surface.
cose metabolism and is not subject toacute regulation. The
major glucose transporter isoforms present in these cells
(GLUTI, GLUT2, and GLUU3, respectively) are constitu-
tively localizedtotheplasma membrane, andthefluxofglu-
cose across themembrane is largelydependentupon the cir-
culating glucose concentration. Muscle andfat cells, on the
other hand, exhibit an acutely regulated glucose transport
system that responds within minutes to factors suchas insu-
lin (Cushmanand Wardzala, 1980; Suzuki andKono, 1980;
Wardzala and Jeanrenaud, 1981).
The regulation of glucose transport in muscle cells and
689adipocytes appears to reflect the unique subcellular targeting
of the glucose transporter in these cells (Blok et al ., 1988;
Slot et al., 1991a,b) . In the basal state the glucose trans-
porters are enriched in tubulo-vesicular structures of the
trans-Golgi reticulum. After stimulation ofthe cells with in-
sulin, the number of glucose transporters at the cell surface
is markedly increased, presumably as a consequence of ac-
celerated exocytosis from the intracellular pool. This mech-
anism for rapidly increasing cellular glucose uptake does not
occur in most other cell types. It is currently unknown
whether the capacity for this acute regulation is the conse-
quence of a cell-specific targeting/translocation apparatus,
or alternatively, reflects the presence of a ubiquitous cellular
machinery that acts in an isoform-specific manner.
The transport of glucose in insulin-sensitive tissues is me-
diated by two transporter isoforms, GLUTI and GLUT4.
GLUT4 is the major isoform present in fat and muscle and
its expression is restricted to insulin-sensitive tissues (James
et al ., 1989; Birnbaum, 1989; Charron et al., 1989 ; Fuku-
moto et al., 1989). GLUTI is expressed in many cell types,
including those that do not normally exhibit insulin-sensitive
glucose transport (Mueckler et al ., 1985; Birnbaum et al.,
1986; Flier et al ., 1987; Fukumoto et al., 1988). Neverthe-
less, both isoforms undergo insulin-dependent movement to
the cell surface in adipocytes (Zorzano et al., 1989; Holman
et al ., 1990; Calderhead et al., 1990; Piper et al ., 1991).
These.observations suggest that the potential for insulin-reg-
ulated translocation of the glucose transporter is conferred
by cell-specific factors. However, recent evidence indicates
that there are targeting differences between the two glucose
transporter isoforms in insulin-sensitive cells. GLUTI and
GLUT4 are located in distinct intracellular vesicles in rat
adipocytes (Zorzano et al., 1989) and 3T3-LI adipocytes
(Piper et al., 1991) . Furthermore, in both cell types the intra-
cellular sequestration of GLUT4 is more efficient than for
GLUTI in the basal state, and because of this the relative in-
crease at the cell surface is greater for GLUT4 than GLUTI
after exposure to insulin. On the basis of these data, it has
been proposed that GLUT4 has evolved as a glucose trans-
porter that is specifically adapted to acute regulation via al-
terations in its subcellular distribution. It is unclear, however,
whether the mechanismsoftransporter sequestration and in-
sulin-sensitive movement operate in cells that do not nor-
mally express GLUT4 or exhibit insulin-sensitive glucose
transport.
We have addressed this question by studying the distribu-
tion of GLUTI and GLUT4 in transfected cell lines that do
not exhibit insulin-stimulated glucose transport. The two
cell types that we have selected for study are 3T3-L1
preadipocytes and HepG2 cells. 3T3-Ll cells replicate in
culture as fibroblast-like preadipocytes and can be induced
to differentiate into insulin-sensitive adipocyte-like cells af-
ter achieving confluence (Kehinde and Green, 1975). The
preadipocytes are insensitive to insulin with respect to glu-
cose transport and express only the GLUTI glucose trans-
porter. During differentiation, GLUT4 expression increases
in parallel with insulin-stimulated glucose transport, and
GLUTI expression declines in parallel with basal transport
(Tordjman et al., 1989) . HepG2 cells express high levels of
GLUTI and, as is the case for 3T3-Ll preadipocytes, do not
exhibit insulin-stimulated glucose transport although they do
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respond to insulin in a variety of other ways (Conover and
Lee, 1990; Adeli and Sinkevitch, 1990).
In the present study we show that human GLUTI is tar-
geted to the cell surface in both HepG2 cells and 3T3-Ll
preadipocytes. Conversely, GLUT4 is excluded from the
plasma membrane and its steady-state distribution in these
cells is indistinguishable from that observed in insulin-
sensitive adipocytes. These data strongly suggest that the in-
tracellular sequestration ofGLUT4, which is fundamental to
insulin regulation, is mediated by factors common to many
cell types. Furthermore, because insulin-dependent move-
ment of GLUT4 to the plasma membrane does not occur in
fibroblasts, it is likely that insulin-sensitive cells express a
unique machinery that acts to recruit transporters from the




3T3-L1 preadipocytes were grown in Dulbecco's modified Eagle's medium
supplemented with 10% calf serum, 50 U/ml penicillin, 50 hg/ml strep-
tomycin, and 2 mM t.-glutamine as described previously (Tordjman et al.,
1989). HepG2 cells were cultured in the same medium supplemented with
10% fetal calf serum rather than calf serum. [3H]-2-Deoxyglucose uptake
was measured as previously described (Tordjman et al., 1989) . Non-
carrier-mediated uptake was measured in the presence of20 PM cytochala-
sin B. Cells were incubated in serum-free medium for 1 h before measure-
ment and insulin-stimulated uptake was determined after an additional
20-min incubation with 10-1 M insulin in serum-free medium. To induce
expression of GLUT4 from the metallothionein promoter of the recombi-
nant bovine papilloma virus vector, confluent 3T3-IRGT25 cells were ex-




Human GLUTI cDNA was obtained by gel purification ofa 2.4-kb BamHI
fragment from pSPGT (Mueckler and Lodish, 1986). GLUT4 cDNA was
obtained by gel purification of a 2-kb EcoRI fragment from pIRGT (James
et al., 1989). The vector used for expression in 3T3-Ll cells was pBPV
MTHXho (kindly provided by Dr. D. H. Hamer, National Institutes of
Health, Bethesda, MD). This vector contains the origin of replication and
the ampicillin-resistance gene ofpML, the 5.5-kb subgenomic transforming
fragment of BPV, and the mouse metallothionein gene (Glanville et al.,
1981) modified by replacement of the BgIII site upstream of the metal-
lothionein gene initiator ATG with a unique XhoI site. pBPVMTHXho
replicates within cells in a stable manner as a multicopy episome and allows
continuous expression offoreign cDNAs independent of chromosomal con-
trols (Campo, 1985). GLUTI and GLUT4 cDNAs were blunt-end sub-
cloned into the XhoI site of pBPVMTHXho in the proper orientation for
expression from the metallothionein promoter.
The plasmid vector pSSFVneo (kindly provided by Dr. Dennis Loh,
Washington University School of Medicine, St. Louis, MO) was used for
expression ofGLUT4 in HepG2 cells. The vector codes for neomycin resis-
tance and expression of foreign cDNAs subcloned into a unique EcoRI site
is driven by the Splenic Focus-Forming Virus LTR (Yamamoto etal., 1981).
The vector contains the polyadenylation and splice sites ofthe SV-40 large
T antigen downstream of the EcoRl cloning site. All DNA constructions
were verified by restriction endonuclease mapping.
Transfection ofMammalian CellLines
Confluent NIH 3T3-L1 fibroblasts were split 1:5 into 10-cm dishes 24 h be-
fore cotransfection (Chen and Okayama, 1987) with 22 jug of a calcium
phosphate precipitate of recombinant BPV vector and pWLneo (Stratagene,
San Diego, CA) in a 10:1 molar ratio. Transfectants were selected by culture
690in 1.0 mg/ml G418 (active fraction 0.52 mg/ml) (Gibco Laboratories, Grand
Island, NY) (Gorman, 1985). G418-resistant colonies were isolated with
cloning rings after 2 wk ofselection, grown to confluence in 24-well tissue
culture plates, and then grown in mass. Confluent HepG2 cells were split
1:3 into 15-cm dishes on the day prior to transfection. Approximately 10'
cells were transfected with 20 ttg of SaII-linearized pSSFVGLUT4 using
Lipofectin (Bio-Rad Laboratories, Richmond, CA) as described by the
manufacturer. A population of stable transfectants was selected in media
containing G418 at 1.0 mg/ml for 1 mo.
Western BlotAnalysis
Transfected cell lines were characterized by SDS-PAGE and Western blot
analysis (James et al., 1989), using one or more of the following primary
antibodies: a rabbit polyclonal antiserum (F349) raised against a synthetic
peptide corresponding to the COOH-terminal 16 residues of rat GLUT4;
a rabbitpolyclonal antiserum (F350) raised against a synthetic peptide cor-
responding to the COOH-terminal 16 residues of human GLUTI; affinity-
purified IgG from a rabbit polyclonal antiserum raised against the purified
human erythrocyte glucose transporter (a kind gift of Dr. G. Lienhard,
Dartmouth Medical School); a monoclonal antibody species specific for the
human GLUTI transporter (Allard and Lienhard, 1985) .
The quantities of the glucose transporter proteins expressed in trans-
fected cell lines were determined relative to standards consisting of either
purified human erythrocyte glucose transporter (to quantitate GLUTI) or
low density microsomes from rat adipocytes (to quantitate GLUT4). The
total glucose transporter content of rat adipocyte low density microsomes
consists of at least 90% GLUT4 (Zorzano et al., 1990). The microsomal
fraction was titrated with cytochalasin B as described (Cushman and Ward-
zala, 1980) and was found to contain 60 pmol of D-glucose-displaceable
binding sites (i.e., total glucose transporter) per mg protein. Blots were
quantitatedusingaphosphorimager (Molecular Dynamics, Sunnyvale, CA).
Confocal ImmunofuorescenceMicroscopy
Sample preparation and confocal immunofluorescence microscopy oftrans-
fected cells were conductedessentially as described previously (Piper et al.,
1991; Tordjman et al ., 1990). Briefly, fibroblasts were grownon glass cover-
slips in 35-mm tissue culture dishes. The slides were rinsed twice with
serum-free medium and then incubated inserum-free medium for 1 h before
fixation. Cells were fixed in 4 % paraformaldehyde at room temperature for
20 min, treated with 100 mM glycine for 10 min, and then permeabilized
with 1% Triton X-100 at room temperature for 15 min before incubation
with primary antibody at 4°C overnight. Slides were then incubated with
fluorescein-conjugated goat anti-rabbit IgG at room temperature for 1 h.
The primary antibody for GLUTI was obtained by affinity purification of
R493 antiserum using the peptideantigen coupled to acrylamide beads. The
primary antibody for detection of GLUT4 was an IgG fraction of F349
GLUT4 antiserum prepared using protein A-Sepharose.
Sucrose Density GradientAnalysis
Two confluent 15-cm dishes of 3T3-IRGT25 fibroblasts were homogenized
(20 strokes) in 3 mil ofHES buffer (20 mM Hepes, 250 mM sucrose, 1 mM
sodium EDTA) using a ground glass homogenizer with a teflondounce. The
resulting homogenates were layered onto 10-ml linear gradients (15-37%
[wt/vol]) containing 20 mM Hepes, pH 7.4, and 1 mM sodium EDTA. Gra-
dients were centrifuged for 10 h at 100,000 g at4°C ina rotor (model SW41;
Beckman Instruments, Inc., Palo Alto, CA). Fractions were collected from
the top of each gradient using a gradient collector (Buchler Instruments,
Fort Lee, NJ) and subjected to SDS-PAGE and immunoblotting using either
R493 or R820 as the primary antibody. Gradients were aligned by both pro-
tein concentration profiles and fraction density.
HepG2 cells were homogenized by passing 12 times through an LSC
homogenizer (Yarnato Scientific, Northbrook, IL) equipped with an LSC
loose-fit pestle at aspeed of 1,200 rpm. The homogenate was then subjected
to sucrose density gradient fractionation as described above. GLUT4 was
immunoprecipitated from each fraction using monoclonal antibody 1F8
(James et al ., 1988) as detailed previously (Piper et al., 1991). Im-
munoprecipitates were subjected to SDS-PAGE and were then immunoblot-
ledusing R820antiserum asthe primary antibody. The GLUT 1 distribution
in the gradients was determined by direct immunoblotting using R493 an-
tiserum as the primary antibody.
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ElectronMicroscopy
Confluent 10-cm dishes of 3T3-IRGT25 fibroblasts were fixed with 2%
paraformaldehyde/0.2 % glutaraldehyde in phosphate-buffered saline, pH
7.2, at room temperature for several hours. Cells were scraped offthe dish
and stored in 0.2% parafortnaldehyde in phosphate-buffered saline, pH 7.2.
Cells were embedded in 10% gelatin as described previously (Slot et al.,
1988), but without fixation of the gelatin (Peters, 1991). Briefly, the cells
were suspended in gelatin at 37°C. After pelleting the cells, the gelatin was
solidified on ice. Blocks for ultracryotomy were prepared and infused with
2 .3 M sucrose overnight at 4°C. Ultrathin sections were prepared, im-
munolabeled, washed, stained with uranylacetate, embedded in methyl cel-
lulose, examined, and photographed as previously described (Slot et al.,
1991x). The antibody usedto localize GLUT 4 (anti-GLUT419) was kindly
provided by Dr. G. E. Lienhard. It was prepared by affinity purification of
a rabbit antiserum against a peptide consisting of the 19 COOH-terminal
amino acids of rat GLUT 4. The secondary reagent was protein A con-




3T3-Ll fibroblasts were cotransfected with a plasmid encod-
ing neomycin resistance and a plasmid containing either
human GLUTI or rat GLUT4 cDNA downstream of the mu-
rine metallothionein-I promoter. Several G418-resistant cell
lines were cloned that expressed either the human GLUT1
or rat GLUT4 proteins. Control cell lines transfected only
with the neomycin-resistance plasmid were also isolated.
The levels of humanand total (human + endogenous mu-
rine) GLUTI protein expressed in the parental 3T3-Ll
preadipocytes, a control transfected line (Neo-1), and two hu-
man GLUTI transfectants (3T3-Hep4 and 3T3-Hep18) are
shown in Fig. 1. Total cellular homogenates (30 Fog protein
per lane) corresponding to each transfectant were subjected
to SDS-PAGE and immunoblotted either with a monoclonal
antibody specific for humanGLUTI or a polyclonal antibody
that recognizes both the human and endogenous murine
GLUTI proteins. Aliquots of purified erythrocyte glucose
transporter were analyzed on the same gel in orderto quanti-
tate the amount oftransporter expressed in transfected lines.
Parental 3T3-L1 fibroblasts and the control Neo-1 line ex-
pressed -170 ng of murine GLUTI per mg of total protein.
The level of total GLUTI was increased 1.6- and 3.2-fold in
3T3-Hep4 and 3T3-Hep18 cells, respectively, relative to con-
trol cells. Consistent with the differential expression of
GLUTI in the two lines, glucose uptake was increased by
2.7- and 4.1-fold, respectively, in 3T3-Hep4 and 3T3-Hepl8
relative to Neo-1 (Fig. 2) . The quantitative difference between
the increase in total GLUT1 protein and the increase in
transport activity in the transfectants may reflect more effi-
cient targeting of the human GLUTI to the cell surface in
3T3-Ll fibroblasts relative to the endogenous murine GLUTI,
or may simply be due to the accuracy of the methods used.
Targeting of GLUTI to the plasma membrane was con-
firmed by laser confocal immunofluorescence imaging (Fig.
3) using an affinity-purified antibody raised against a 12-ami-
no acid synthetic peptide corresponding to the COOH ter-
minus of GLUTI. The plasma membrane of 3T3-Hep4 pre-
adipocytes was most prominently labeled, but intracellular
staining was also evident. This is qualitatively similar to the
GLUTI labeling that is observed in 3T3-Ll adipocytes, ex-
cept that in adipocytes the ratioofplasma membrane to intra-
69 1cellular labeling is considerably lower. The labeling observed
was specific for GLUTI as it was completely quenched in the
presence of the peptide antigen (data not shown) .
The levels of ratGLUT4 in two transfected cell lines (3T3-
IRGT14 and 3T3-IRGT25) and several control lines are
shown in Fig . 4 . Aliquots ofrat adipocyte low density micro-
somes, previously subjected to a cytochalasin B binding as-
say to estimate the GLUT4 protein content, were included
on the gel as quantitative standards (see Materials and
Methods) . As shown previously (James et al., 1989 ; Tordj-
man et al., 1989), GLUT4 was not detected in 3T3-Ll
preadipocytes and was present at 65 ng per mg total cellular
protein in differentiated adipocytes . The level of expression
ofGLUT4 in 3T3-IRGT25 (60 ng per mg total protein) was









Figure 2 . Glucose transport activity in 3T3-LI cell lines expressing
human GLUT1 . ['H]-2-Deoxyglucose uptake assays were con-
ducted as described in Materials and Methods on cell lines grown
to confluence in 35-mm plates. Values represent means t SE of
six determinations .
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Figure 1. GLUTI expression in 3T3-Ll cell lines.
Duplicate 30-,ug aliquots oftotal detergent-soluble
protein fractions were electrophoresed on each of
two 10% polyacrylamide gels and the gels sub-
jected to Western blotting as described in Materi-
als and Methods . The upper blot was incubated
with a polyclonal antibody (PAB) that recognized
boththehuman andthe endogenousmurine GLUTI
proteins . The lower blot was probed with a mono-
clonal antibody (MAB) that recognized only hu-
man GLUTI . The numbers above the blots repre-
sent nanograms of purified erythrocyte glucose
transporter loaded on the gels as quantitative stan-
dards. 3T3LI(F), parental 3T3-Ll fibroblasts.
in response to a combination of butyrate and ZnC12 treat-
ment ofthe cells. Induced 3T3-IRGT25 cells exhibited about
a twofold increase in the expression of total glucose trans-
porter (endogenous murine GLUTI + ratGLUT4) relative
to nontransfected preadipocytes and the control Neo-1 line.
In contrast to the GLUTI transfectants, no increase in basal
glucose transport was observed in GLUT4-transfected lines
(Fig. 5) . The rate of 2-deoxyglucose uptake measured in the
transfected lines was unaffected by acute treatment of the
cells with 100 nM insulin . Induction ofGLUT4 protein by
incubation of cells in the presence of butyrate and zinc had
no effect on transport activity in the presence or absence of
insulin (data not shown) .
Consistent with these observations, GLUT4 appeared by
laser confocal immunofluorescence imaging to be localized
almost entirely within cytoplasmic structures in 3T3-
IRGT25 cells (Fig. 3) . The staining was concentrated in a
discrete perinuclear region and was also observed in a punc-
tate pattern throughout the cytoplasm . This staining pattern
is very similar to that observed for the endogenous murine
GLUT4 in the differentiated adipocytes (Piper et al., 1991) .
However, in contrast to our observations in 3T3-Ll adipo-
cytes, no change was seen in the distribution ofGLUT4 in
3T3-IRGT25 preadipocytes following stimulation ofthe cells
with insulin or IGF-I (data not shown) .
Because of the similarity in GLUT4 labeling by indirect
immunofluorescence between 3T3-Ll adipocytes and the
transfected preadipocytes, the distribution of rat GLUT4 in
3T3-IRGT25 cells was investigated at the ultrastructural
level by immunogold labeling of frozen thin sections (Fig . 6,
bottom) . Staining was heavily concentrated in tubulo-vesic-
ular elements of the trans-Golgi reticulum . Labeling of the
cell surface was very low. The staining pattern was veryFigure 3 . Visualization of GLUTI and GLUT4 transfected preadipocyte cell lines . 3T3-Hep4 (left) and 3T3-IRGT25 (right) cells were
grown on glass coverslips andprocessed for indirect immunofluorescence-laser confocal microscopy as described in MaterialsandMethods .
Representative lower (bottom) and higher (top) magnification fields are shown . Note that staining is not apparent in cells that are out of
the focal plane of the laser. Control slides incubated with antibody mixed with an excess of a rat COOH-terminal GLUTI peptide did
not exhibit any immunofluorescence, and the control 3T3-Neo-1 line did not exhibit any background immunofluorescence with 000H-
terminal GLUT4 antibody (data not shown) . Bars : (top right and bottom) 25 Am ; (top left) 10 Am .
similar to that observed previously for endogenous GLUT4
in various insulin-sensitive cells, i.e ., basal (non-insulin
treated) brownadipocytes (Slot et al ., 1991a), 3T3-Ll adipo-
cytes (Piper et al ., 1991), and cardiac muscle (Slot et al .,
1991b) .
Figure 4 . GLUT4 expression
in3T3-Ll cell lines . 30-pg ali-
quots of total cellular protein
from each cell line were elec-
tmphoresed on 10%polyacryl-
amide gels and the gels sub-
jected to Western blotting as
described in Materials and
Methods . The primary anti-
body used (F349) was specific
for the GLUT4 transporter.
373I1(F), parental 3T3-Ll preadipocytes ; 373I1(A), parental 3T3-
Ll adipocytes ; IRGT-14(1), 3T3-IRGT14 cells induced with butyrate
and ZnCI Z; IRGT--25(1), 3T3-IRGT25 cells induced with butyrate
and ZnCI Z .
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Unfortunately, we were unable to immunolocalizeGLUTI
in 3T3-Ll fibroblasts at the EM level because of the low
efficiency of labeling of the protein in frozen thin sections .
Therefore, to confirm the differential targeting of GLUTI
and GLUT4 in the fibroblasts we performed sucrose density
gradient centrifugation (Fig . 7) . Total cellular homogenates
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Figure 5 . Glucose transport
activity in 3T3-Ll cell lines
expressing rat GLUT4. Con-
fluent 35-mm plates of cells
were eitheruntreated ortreated
with 100 nM insulin for 20
min. 2-Deoxyglucose uptake
assays were performed as de-
scribed inMaterialsandMeth-
ods . Values represent means
t SE of six measurements .The Journal of Cell Biology, Volume 114, 1991
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694Figure 7 . Sucrose density gradient analysis of GLUTI- and GLUT4-containing membranes in 3T3-IRGT25 preadipocytes . Atotal cellular
homogenate was prepared from 3T3-IRGT25 fibroblasts and layered onto a 10-37% sucrose gradient. After centrifugation to equilibrium,
gradient fractions were collected and subjected to SDS-PAGE and immunoblotting using antibodies specific for either GLUTI (top) or
GLUT4 (bottom) . The mobility of molecular mass standards is indicated on the left . The numbers below the autoradiograms represent
the fractions collected beginning from the top of the gradient .
of 3T3-IRGT25 cells were layered onto 15-37% linear su-
crose gradients and centrifuged to equilibrium . Gradient
fractions were collected andimmunoblotted with antibodies
specific for either GLUTI or GLUT4 . Both transporters ex-
hibited a bimodal distribution on these gradients . GLUTI
was concentrated in high density fractions (mean density
-1.15 g/cm 3) in each gradient examined (n = 4) . Based
upon theimmunofluorescence data (see above), this presum-
ably reflects the distribution of plasma membrane in these
gradients . Another peak ofGLUTI, representing -10% of
the total, migrated at a mean density of -1.10 g/cm3 (frac-
tions 11-13) . These lower density fractions presumably rep-
resent the intracellular pool ofGLUTI. The smaller size of
this pool is consistent with theimmunofluorescence data (see
above) . GLUT4 was concentrated in fractions 5-11 (mean
density -1.09 g/cm 3) of all gradients (n = 4) with -30
being detected in denser fractions . The fibroblast-like
preadipocytes are difficult to break open so thataportion of
Figure 6 . Ultrastructural localization ofGLUT4 and GLUTI . Frozen thin sections of HepG2 cells (top) or 3T3-IRGT25 preadipocytes
(bottom) were stained with an antibody specific for the COOH terminus ofGLUTI or GLUT4, respectively, followed by protein A com-
plexed to 10-nm gold particles . G, Golgi cisternae; asterisks, trans-Golgi reticulum; arrows, tubulo-vesicular elements . Bar, 500 nm.
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696the localization ofGLUT4 in the denser fractions may be due
to the presence of unbroken and partially broken cells near
the bottom ofthe gradient. However, we cannot rule out the
possibility that some GLUT4 in the denser fractions may
represent plasma membrane localization that was too low to
detect by immunofluorescence or a denser pool of intracellu-
lar vesicles. It is also conceivable that the COOH-terminal
epitope of GLUT4 is selectively masked in the plasma mem-
brane of 3T3-LI preadipocytes. We consider this unlikely
because the epitope is not masked in the plasma membrane
of insulin-treated 3T3-Ll adipocytes (Piper et al., 1991),or
in the intracellular pool of 3T3-IRGT25 preadipocytes.
The immunofluorescence, EM, and sucrose gradient data
together suggest that the lower density fractions containing
the bulk of GLUT4 represent the distribution of the trans-
Golgi reticulum and tubulo-vesicular elements of 3T3-Ll
fibroblasts. It is noteworthy that the profiles of GLUTI and
GLUT4 in the putative intracellular fractions do not coin-
cide. This is consistent with the distinct distribution ofthese
two isoforms in 3T3-L1 adipocytes (Piper et al ., 1991) and
rat adipocytes (Zorzano et al., 1990). We also subjected
purified intracellular membranes from both rat and 3T3-Ll
adipocytes to sucrose density gradient analysis in parallel
with total cellular homogenates from the 3T3-IRGT25 clone.
The density of the putative intracellular GLUT4-containing
vesicles from each cell type was identical (data not shown).
In contrast to what we previously observed in adipocytes
(Piper et al., 1991), there was no significant change in the
sucrose gradient distribution of GLUTI or GLUT4 in 3T3-
IRGT25 following incubation with insulin/IGF-I (data not
shown) .
Distribution ofGLU77 and GLUT4 in HepG2
Hepatoma Cells
To extend our findings concerning the localization ofthe glu-
cose transporters to an additional cell type that is refractory
to insulin-stimulated glucose transport, we investigated the
distribution of GLUTI and GLUT4 in a human hepatoma
cell line, HepG2 . GLUT4-expressing HepG2 cells were ob-
tained after transfection of cells with an expression vector
containing GLUT4 cDNA downstream of the Splenic Focus
Forming Virus long terminal repeat and also containing the
neomycin-resistance gene driven by the SV40 large T anti-
gen promoter. Because of the very slow growth rate of
HepG2 cells, we were unsuccessful in obtaining single
GLUT4 positive clones. Therefore, we performed our analy-
ses using a pooled stock of G418-resistant clones. Only a
subset of these cells actually expressed the GLUT4 protein,
so that the overall expression was quite low. Total homog-
enates of this HepG2 GLUT4 pool were subjected to sucrose
density gradient analysis as described above for 3T3-Ll cells.
The level of GLUT4 expression was too low in these cells
to visualize by direct immunoblotting or microscopy. There-
fore, in order to detect the distribution of GLUT4 by sucrose
density gradientcentrifugation, an equalvolume ofeach frac-
tion was solubilized and subjected to quantitative immu-
noprecipitation using a monoclonal antibody specific for
GLUT4 (James et al., 1988). The immunoprecipitates were
then analyzed by SDS-PAGE and immunoblotting using a
polyclonal antibody specific for GLUT4. GLUTI was de-
tected by directly immunoblotting a smaller proportion of
the identical gradientfractions used for detection ofGLUT4.
The two transporter isoforms exhibited distinct distribu-
tion patterns on the sucrose gradients (Fig. 8). GLUT1,
which appears to be a marker for the plasma membrane in
these cells (see below), was present almost exclusively in
dense fractions at the very bottom of the gradient. There was
no detectable GLUT4 in these fractions. A high molecular
mass band (M -170 kD) corresponding to the IgG from
the beads used for immunoprecipitation was detected in each
lane ofthe GLUT4 immunoblot. A protein of the appropriate
molecular mass for GLUT4 (N43 kD) was concentrated in
fractions 7-11 after immunoprecipitation. The density of
these fractions (mean -1.09 g/cm3) was similar to that of
the GLUT4 peak in 3T3-IRGT25 preadipocytes. These data
demonstrate that GLUTI and GLUT4 are targeted to distinct
subcellular compartments in HepG2 cells.
To clarify the nature of the different glucose transporter-
containing subcellular compartments in HepG2 cells,
GLUTI was localized in these cells by immunogold labeling
of frozen thin sections. The transporter was found predomi-
nantly in the plasma membrane (Fig. 6, top). Gold particles
were concentrated on the cytoplasmic face ofthe membrane,
consistent with the cytoplasmic localization of the 000H-
terminal domain of the erythrocyte transporter (Davies et
al., 1990) . Taken as a whole the HepG2 data suggest that
GLUT4 is present in intracellular vesicles, perhaps derived
from the trans-Golgi reticulum. Unfortunately, GLUT4
could not be localized directly in the HepG2 transfectants by
electron microscopy because of its low level of expression.
Discussion
The major mechanism by which insulin stimulates glucose
transport in adipocytes is by eliciting the redistribution of
GLUT4 from an intracellular compartment to the cell sur-
face (Holman et al., 1990; Calderhead et al., 1990; Piper
et al., 1991) . What makes this process so dramatic is the vir-
tual exclusion of GLUT4 from the cell surface in the absence
of insulin. Our data demonstrate that the appropriate intra-
cellular targeting of GLUT4 occurs in cells that do not ex-
hibit insulin-sensitive glucose transport and do not normally
Figure 8. Sucrose density gradient analysis of GLUTI- and GLUT4-containing membranes in HepG2 cells. A total cellular homogenate
from a population of HepG2 cells expressing rat GLUT4 was layered onto a 10-37% sucrose gradient and centrifuged to equilibrium.
Gradient fractions were subjected to quantitative immunoprecipitation with monoclonal antibody IF8 and the immunoprecipitates were
then analyzed by SDS-PAGE and immunoblotting using polyclonal antibody R820 specific for GLUT4. The distribution of GLUTI in the
gradients was determined by direct SDS-PAGE and immunoblotting of gradient fractions using a primary antibody (R493) specific for
GLUTI. The numbers below the autoradiograms represent the collected fractions beginning from the top of the gradient. The mobility
of molecular mass standards of 36 and 48 kD is indicated on the left. The high molecular mass bands in the GLUT4 autoradiogram cor-
respond to the IgG present in the beads used for immunoprecipitation of GLUT4 from the gradient fractions.
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697express this transporter isoform. In contrast, GLUTI is
sorted principally to the plasma membrane under the same
conditions.
We have previously characterized the intracellular com-
partment containing GLUT4 (GTV, glucose transporter
vesicle) in a variety of insulin-sensitive cells, including 3T3-
Ll adipocytes (Piper et al ., 1991; Gould et al., 1989), rat
adipocytes (Slot et al., 1991x; James et al., 1987), and rat
cardiac muscle (Slot et al ., 1991b). Similar experimental
protocols were applied to study the intracellular location of
GLUT4 in 3T3-L1 fibroblasts and HepG2 cells. Both the
morphological and biochemical characteristics of the GTV
appeared identical between insulin-sensitive and non-insulin-
sensitive cells. Using immunocytochemistry we found that
GLUT4 is enriched in tubulo-vesicular elements in 3T3-Ll
fibroblasts and adipocytes as well as in rat brown adipo-
cytes and cardiac myocytes. Furthermore, the density in su-
crose gradients of the GTV is very similar among different
cell types. These data strongly suggest that the targeting of
GLUT4 to a common or similar GTV occurs in both insulin-
sensitive and insensitive cells.
At present little is known about the nature ofthe intracellu-
lar GTV. Although it may represent a unique organelle, we
cannot exclude the possibility that it corresponds to a sub-
compartment of an organelle such as the trans-Golgi reticu-
lum. The major problem in characterizing the GTV is that
apart from GLUT4 there are no known markers that distin-
guish it from other elements of the endocytic pathway.
Whereas most of the cellular GLUTI is targeted to the
plasma membrane in HepG2 cells and 3T3-Ll fibroblasts, a
smaller intracellular pool of GLUTI is also evident. A char-
acteristicof insulin-sensitive cells is that GLUTI is primarily
located within intracellular vesicles that are distinct from
those vesicles containing GLUT4. Similarly, in non-insu-
lin-sensitive cells the intracellular pool of GLUTI is distinct
from the intracellular pool of GLUT4. This is an important
criterion which lends support to the notion that GLUT4 is
targeted correctly in cells that do not normally express this
molecule. It remains to be determined whether the primary
function of the GTV is for the intracellular sequestration of
GLUT4 under basal conditions or to shuttle GLUT4 mole-
cules to the cell surface after exposure to insulin. It has been
proposed that GLUT4 constitutes a substantial proportion of
GTV protein (up to 15 %) in adipocytes (Zorzano et al. ,
1989) . By analogy with secretory granules, this could be an
indication that a major function of the GTV is related to
GLUT4. This raises the question as to whether the GTV is
a compartment or organelle present in all cells that has func-
tions unrelated to GLUT4 . Alternatively, as has been pro-
posed for secretory granules (Wagner et al., 1991), the ex-
pression of GLUT4 in a particular cell might trigger the
biogenesis of the GTV.
The subcellular targeting ofGLUT4 appears to be isoform
specific. Thus, GLUT4 presumably contains a subcellular
targeting motif, absent in other transporter isoforms, that is
recognized by a ubiquitously expressed cellular targeting
machinery. This motif could be a linear stretch of amino
acids or a posttranslational modification. The N- and C-ter-
minal cytoplasmic domains of GLUT4 are unique compared
to the othertransporter isoforms, and these regions are likely
candidates for containing a sorting motif. The observations
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described here provide an obvious method for the identifica-
tion of the targeting signal.
A major property of insulin-sensitive cells that was not
apparent in 3T3-Ll fibroblasts or HepG2 cells is the reg-
ulated movement of GLUT4 to the cell surface following
exposure to insulin or IGF-I. We were unable to detect move-
ment of GLUT4 to the cell surface by measurement of glu-
cose transport, sucrose density gradient analysis, or immu-
nofluorescence microscopy. These are all techniques that
have previously been used to document insulin-dependent
translocation of GLUT4 in 3T3-L1 adipocytes (Piper et al.,
1991). It is likely that a similar magnitude ofGLUT4 translo-
cation in the preadipocytes could have been detected, since
the level of expression of the transporter in the fibroblasts
was comparable'to that observed in either 3T3-L1 or rat adi-
pocytes. 3T3-LI adipocytes possess a markedly insulin-sen-
sitive glucose transport system, and in these cells a smaller
percentage of the intracellular GLUT4 is translocated to the
cell surface after maximal stimulation with insulin (Piper et
al., 1991) compared with that seen in rat adipocytes (James
et al ., 1988, 1989). Thus, we cannot exclude the possibility
that in 3T3-Ll preadipocytes a very small percentage of the
intracellular GLUT4 may have been translocated to the
membrane in a regulated manner. Furthermore, insulin-
stimulated movement of GLUT4 into other intracellular
compartments, such as endosomes and coated vesicles, has
also been observed in adipocytes (Slot et al., 1991x). The
resolution of the techniques used in the present studies may
have been insufficient to resolve changes of this nature.
Our data suggest that non-insulin-sensitive cells express
the appropriate factors required for the intracellular target-
ing of GLUT4, but the additional machinery required to re-
cruit GLUT4 from this compartment to the cell surface in
response to insulin is missing. This is an important observa-
tion because it suggests that the targeting and recruitment of
GLUT4 are independent phenomena. The absence of the
translocation response is not due to the lack of insulin recep-
tors in the preadipocytes (Reed et al., 1976) ; however, it is
possible that the signaling pathway used by insulin to pro-
mote GLUT4 translocation is not present.
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